Canada · Delayed Price · Currency is CAD Extendicare Statistics
Total Valuation
Extendicare has a market cap or net worth of CAD 3.08 billion. The enterprise value is 3.08 billion.
| Market Cap | 3.08B |
| Enterprise Value | 3.08B |
Important Dates
The last earnings date was Thursday, May 7, 2026.
| Earnings Date | May 7, 2026 |
| Ex-Dividend Date | May 29, 2026 |
Share Statistics
Extendicare has 94.82 million shares outstanding. The number of shares has decreased by -3.57% in one year.
| Current Share Class | 94.82M |
| Shares Outstanding | 94.82M |
| Shares Change (YoY) | -3.57% |
| Shares Change (QoQ) | +6.97% |
| Owned by Insiders (%) | 1.36% |
| Owned by Institutions (%) | 32.39% |
| Float | 93.47M |
Valuation Ratios
The trailing PE ratio is 23.75 and the forward PE ratio is 21.03.
| PE Ratio | 23.75 |
| Forward PE | 21.03 |
| PS Ratio | 1.76 |
| PB Ratio | 7.82 |
| P/TBV Ratio | 15.33 |
| P/FCF Ratio | 34.78 |
| P/OCF Ratio | 21.90 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 16.39, with an EV/FCF ratio of 34.82.
| EV / Earnings | 25.16 |
| EV / Sales | 1.76 |
| EV / EBITDA | 16.39 |
| EV / EBIT | 19.68 |
| EV / FCF | 34.82 |
Financial Position
The company has a current ratio of 1.44, with a Debt / Equity ratio of 0.83.
| Current Ratio | 1.44 |
| Quick Ratio | 1.34 |
| Debt / Equity | 0.83 |
| Debt / EBITDA | 1.75 |
| Debt / FCF | 3.67 |
| Interest Coverage | 7.89 |
Financial Efficiency
Return on equity (ROE) is 47.21% and return on invested capital (ROIC) is 31.16%.
| Return on Equity (ROE) | 47.21% |
| Return on Assets (ROA) | 10.79% |
| Return on Invested Capital (ROIC) | 31.16% |
| Return on Capital Employed (ROCE) | 20.50% |
| Weighted Average Cost of Capital (WACC) | 10.01% |
| Revenue Per Employee | 74,510 |
| Profits Per Employee | 5,207 |
| Employee Count | 23,500 |
| Asset Turnover | 1.96 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Extendicare has paid 38.20 million in taxes.
| Income Tax | 38.20M |
| Effective Tax Rate | 23.79% |
Stock Price Statistics
The stock price has increased by +112.13% in the last 52 weeks. The beta is 1.15, so Extendicare's price volatility has been higher than the market average.
| Beta (5Y) | 1.15 |
| 52-Week Price Change | +112.13% |
| 50-Day Moving Average | 29.91 |
| 200-Day Moving Average | 22.10 |
| Relative Strength Index (RSI) | 43.08 |
| Average Volume (20 Days) | 418,352 |
Short Selling Information
The latest short interest is 1.59 million, so 1.90% of the outstanding shares have been sold short.
| Short Interest | 1.59M |
| Short Previous Month | 1.60M |
| Short % of Shares Out | 1.90% |
| Short % of Float | 2.22% |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Extendicare had revenue of CAD 1.75 billion and earned 122.36 million in profits. Earnings per share was 1.37.
| Revenue | 1.75B |
| Gross Profit | 255.63M |
| Operating Income | 154.10M |
| Pretax Income | 160.55M |
| Net Income | 122.36M |
| EBITDA | 182.33M |
| EBIT | 154.10M |
| Earnings Per Share (EPS) | 1.37 |
Balance Sheet
The company has 320.89 million in cash and 324.56 million in debt, with a net cash position of -3.67 million or -0.04 per share.
| Cash & Cash Equivalents | 320.89M |
| Total Debt | 324.56M |
| Net Cash | -3.67M |
| Net Cash Per Share | -0.04 |
| Equity (Book Value) | 393.16M |
| Book Value Per Share | 4.15 |
| Working Capital | 141.34M |
Cash Flow
In the last 12 months, operating cash flow was 140.43 million and capital expenditures -52.01 million, giving a free cash flow of 88.42 million.
| Operating Cash Flow | 140.43M |
| Capital Expenditures | -52.01M |
| Depreciation & Amortization | 28.23M |
| Net Borrowing | 34.14M |
| Free Cash Flow | 88.42M |
| FCF Per Share | 0.93 |
Margins
Gross margin is 14.60%, with operating and profit margins of 8.80% and 6.99%.
| Gross Margin | 14.60% |
| Operating Margin | 8.80% |
| Pretax Margin | 9.17% |
| Profit Margin | 6.99% |
| EBITDA Margin | 10.41% |
| EBIT Margin | 8.80% |
| FCF Margin | 5.05% |
Dividends & Yields
This stock pays an annual dividend of 0.51, which amounts to a dividend yield of 1.58%.
| Dividend Per Share | 0.51 |
| Dividend Yield | 1.58% |
| Dividend Growth (YoY) | 5.00% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 35.62% |
| Buyback Yield | 3.57% |
| Shareholder Yield | 5.15% |
| Earnings Yield | 3.98% |
| FCF Yield | 2.88% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for Extendicare is 38.28, which is 25.06% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 38.28 |
| Price Target Difference | 25.06% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 9 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Extendicare has an Altman Z-Score of 3.28 and a Piotroski F-Score of 6.
| Altman Z-Score | 3.28 |
| Piotroski F-Score | 6 |